Finance

Beta
Lists
PERCF:OTCMKTS
Percheron Therapeutics Ltd
$0.0020
0.00%
(0.00) 1D
May 22, 10:46:47 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PERCF...
Mkt. cap
3.81M
Avg. vol.
256.00
Volume
0.00
52-wk high
$0.02
52-wk low
$0.00
Beta
1.61
Shares outstanding
1.52B
No. of employees
8
Mkt. cap
3.81M
Avg. vol.
256.00
Volume
0.00
52-wk high
$0.02
52-wk low
$0.00
Beta
1.61
Shares outstanding
1.52B
No. of employees
8
News stories
From sources across the web
About Percheron Therapeutics Ltd
CEOJames Garner
Employees8
Founded2000
HeadquartersToorak, Victoria, Australia
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
824.64K
824.64K
44.20K
44.20K
Cost of goods sold
35.46K
35.46K
58.63K
58.63K
Cost of revenue
35.46K
35.46K
58.63K
58.63K
Research and development expenses
2.31M
2.31M
671.18K
671.18K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.12M
1.12M
732.56K
732.56K
Operating expense
4.01M
4.01M
1.53M
1.53M
Total operating expenses
4.05M
4.05M
1.59M
1.59M
Operating income
-3.22M
-3.22M
-1.55M
-1.55M
Other non operating income
-
-
-
-
EBT including unusual items
-3.19M
-3.19M
-1.55M
-1.55M
EBT excluding unusual items
-3.19M
-3.19M
-1.55M
-1.55M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.19M
-3.19M
-1.55M
-1.55M
Net profit margin
-387.20%
-387.20%
-3,512.84%
-3,512.84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.95K
-1.95K
-5.29K
-5.29K
Net interest expenses
-1.95K
-1.95K
-5.29K
-5.29K
Depreciation and amortization charges
15.93K
15.93K
9.56K
9.56K
EBITDA
-3.21M
-3.21M
-1.54M
-1.54M
Gain or loss from assets sale
914.00
914.00
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more